DPSIP yields 392.16% · PFE yields 6.13%● Live data
📍 DPSIP pulled ahead of the other in Year 1
Combined, DPSIP + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DPSIP + PFE for your $10,000?
Decisionpoint Systems, Inc. provides and integrates enterprise mobility and wireless applications solutions that delivers improved productivity and operational advantages to its clients by helping to move business decision points closer to its customers. It makes enterprise software applications accessible to the front-line worker anytime, anywhere. The company utilizes wireless, mobility, and RFID technologies. It sells, installs, deploys, and repairs mobile computing and wireless systems, such as mobile computers and application software; and related data capture equipment, including bar code scanners and radio frequency identification readers for the retail, warehousing and distribution, healthcare, wholesale distribution, and field sales and service industries. The company also offers lifecycle management, and project management and deployment services; and managed services, such as consulting, technology acquisition, project management, software integration and development, deployment, repair services, service desk, and reverse logistics and end of life disposal services, as well as OnPoint Service Hub, a customer service portal that provides customers real-time asset management and tracking information. In addition, it provides MobileConductor, a software platform that provides complete in-vehicles solutions; VizeTrace, a software platform that manages RFID installations; and custom software development services, as well as resells specialized independent software vendors applications. The company is headquartered in Laguna Hills, California.
Full DPSIP Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.